Neonc Technologies Holdings, Inc.
NASDAQ:NTHIBiotechnology
+$0.14 today
- Market cap
- $120.02M
- Beta
- 0.29
- P/E (TTM)
- -3.0
- EPS (TTM)
- -$1.66
Volume 0.27M
Average 0.08M
NTHI Capital Expenditures
Cash spent on property, plant, equipment, and other long-term assets.
Neonc Technologies Holdings, Inc.NASDAQ: NTHI
Capital Expenditures · Q1 FY2026 · quarter ended Mar 2026
Capital expenditures turns positive
Q1 FY2026 capital expenditures was $3, compared with -$5 a year earlier. Trailing-twelve-month capital expenditures was $8.
Context
- Capital expenditures amounted to 1250.3% of revenue in FY2025.
What to watch
Whether quarterly capital expenditures holds near $3 or moves back toward the trailing-twelve-month quarterly average of $2.
Sources:Cash FlowText generated from reported figures; not investment advice.
Capital Expenditures history
USD · from the cash flow
- Latest · FY2025
- (500K) USD
- Year-over-year change
- —
| Period | Period end | Capital Expenditures | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (500K) | — |
Capital Expenditures vs competitors
How NTHI compares with its peers on the latest reported figures
No competitor Capital Expenditures figures are available to compare.
Cash Flow Statement
Neonc Technologies Holdings, Inc.
NASDAQ:NTHI
Intrinsic Alpha fair value
Locked
Current Price
$4.16
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.